Amazon Teams Up with Berry Street to Expand Access to Nutrition Therapy
Amazon has added Berry Street to its Health Benefits Connector to help customers discover and access insurance-covered nutrition therapy services through its platform. The post Amazon Teams Up with Berry Street to Expand Access to Nutrition Therapy appeared first on MedCity News.
The Uninsured Rate Is Soaring — What Can Providers Do About It?
New research from Cedar found that about 40% of collectible healthcare dollars now come from uninsured patients, a share that has jumped 54% in three years. The shift is forcing providers to rethink their revenue cycle strategies as patient payments become more difficult — and more important — to collect. The post The Uninsured Rate…
What the Health? From KFF Health News: GOP Mulls More Health Cuts
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Debunked Episode 25: Sutter Health’s Allina Health Acquisition Strategy, a Deep Dive on Doctronic
In the latest episode of the Debunked podcast, MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, discussed recent M&A deals and how bots can be manipulated. The post Debunked Episode 25: Sutter Health’s Allina Health Acquisition Strategy, a Deep Dive on Doctronic appeared first on MedCity News.
Q&A: Empowerment Over Information – Rethinking Patient Education
Dr. Thomas Schenk discusses health literacy
Why Biogen Is Paying $5.6B to Buy Apellis Pharma
Biogen’s Apellis Pharmaceuticals acquisition comes nearly two years after the drugmaker purchased immunology startup Human Immunology Biosciences. CEO Chris Viehbacher said Apellis accelerates Biogen’s expansion in nephrology, supporting a HI-Bio drug currently in pivotal testing for three kidney conditions. The post Why Biogen Is Paying $5.6B to Buy Apellis Pharma appeared first on MedCity News.
AI-Powered Cohorting Is Quietly Reshaping How Real-World Evidence Gets Built
The organizations that benefit the most from AI-powered cohorting will not simply be those that move faster. They will be those that embed patient mastering and semantic rigor into reproduceable, inspectable workflows. The post AI-Powered Cohorting Is Quietly Reshaping How Real-World Evidence Gets Built appeared first on MedCity News.
To Bend the Curve on Heart Disease, Prevention Must Move Upstream
Heart disease is the leading cause of death in the U.S., yet with Americans lacking access to preventive heart screenings, we’re stuck in a cycle of treating symptoms rather than preventing disease The post To Bend the Curve on Heart Disease, Prevention Must Move Upstream appeared first on MedCity News.
AI Drug Discovery Is Reshaping Longevity Medicine. Is Your Practice Ready?
More therapeutic options times more data per option times the same number of clinical hours equals something that breaks. The practices that will thrive when the next wave of longevity therapeutics arrives are the ones that have already solved this. The post AI Drug Discovery Is Reshaping Longevity Medicine. Is Your Practice Ready? appeared first…